Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
Más filtros











Intervalo de año de publicación
1.
Int J Dermatol ; 31(11): 813-7, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1428437

RESUMEN

We report on the histologic changes occurring in single cutaneous lesions, from six active lepromatous patients, 1 week following the administration of three daily intradermal injections, 35 micrograms each, of recombinant interferon gamma (rIFN-gamma). Except for a strong induration at the injection site, rIFN-gamma produced no adverse systemic reactions and was able to promote a remarkable influx of T-lymphocytes, mononuclear phagocytes with large nuclei, nonvacuolated cytoplasm, and reduced lysozyme reactivity. Furthermore, despite no clear-cut reduction of mycobacterial dermal burden, bacilli showed a clear increase in the granular appearance. Present findings provide a basis for further elucidation of rIFN-gamma as an additional tool for leprosy treatment.


Asunto(s)
Interferón gamma/uso terapéutico , Lepra Lepromatosa/terapia , Piel/patología , Adulto , Anciano , Biopsia , Esquema de Medicación , Femenino , Humanos , Inyecciones Intralesiones , Interferón gamma/administración & dosificación , Lepra Lepromatosa/patología , Masculino , Persona de Mediana Edad , Proteínas Recombinantes , Factores de Tiempo
4.
Parasite Immunol ; 13(6): 639-47, 1991 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1811215

RESUMEN

The degree of resistance to a local Leishmania amazonensis challenge has been compared in lines of mice obtained by selective breeding for high or low immunoresponsiveness: High and Low antibody responder mice of Selections I and II (HI, HII and LI, LII lines) and high and low responder mice to T mitogen PHA (Hi/PHA and Lo/PHA). The aim of this preliminary study was to focus attention on genetic differences related with well defined immune characteristics. Clear-cut results were obtained, both HI and HII mice developed large and disseminating lesions, the rate of symptom aggravation being faster in HII, while LI and LII proved resistant to parasites, only small and transient lesions being observed for them during a 150 days follow up. The outcome of infection also differs in Hi/PHA and Lo/PHA mice, Hi/PHA having a resistant and Lo/PHA a susceptible phenotype.


Asunto(s)
Anticuerpos Antiprotozoarios/biosíntesis , Variación Genética/inmunología , Leishmania mexicana/inmunología , Leishmaniasis Cutánea/inmunología , Animales , Susceptibilidad a Enfermedades , Ensayo de Inmunoadsorción Enzimática , Leishmaniasis Cutánea/genética , Ratones , Ratones Mutantes
5.
Eur Cytokine Netw ; 2(4): 299-303, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1721851

RESUMEN

This study investigates the effect of intraperitoneal injection of L. bulgaricus and S. thermophilus on interferon production by Swiss mice. The serum from mice given 5 x 10(7) L. bulgaricus in 0.5 ml saline showed a maximal production of 300 U/ml of alpha/beta interferon activity six hours after injection. Cellular integrity appears to be necessary for stimulation; heat-treated bacteria had little effect, while irradiated-bacteria had a greater effect. TNF was also produced, the sera of mice with high IFN also contained 300 U/ml TNF. Streptococcus thermophilus produced no detectable increase in serum IFN, but the 2'-5' A synthetase activity of peritoneal cells was elevated suggesting that small amounts of interferon were produced. Injection of Streptococcus thermophilus plus Lactobacillus bulgaricus did not change the serum interferon response to L. bulgaricus. These observations suggest that non-pathogenic bacteria such as those used in food processing, can stimulate IFN production in mice. There is some evidence that the bacterial cell walls might be responsible for at least part of this effect.


Asunto(s)
Infecciones Bacterianas/inmunología , Inductores de Interferón , Interferones/biosíntesis , Lactobacillus , Infecciones Estreptocócicas/inmunología , 2',5'-Oligoadenilato Sintetasa/metabolismo , Animales , Infecciones Bacterianas/enzimología , Supervivencia Celular/efectos de los fármacos , Dactinomicina/farmacología , Femenino , Interferones/análisis , Interferones/sangre , Células L , Lactobacillus/efectos de la radiación , Ratones , Infecciones Estreptocócicas/enzimología , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/farmacología
6.
J Infect Dis ; 163(4): 853-7, 1991 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1901333

RESUMEN

High tumor necrosis factor-alpha (TNF alpha) levels were present in the serum of 24 of 28 active visceral leishmaniasis (VL) patients (142.9 +/- 113.9 pg/ml, mean +/- SD), whereas levels were not elevated in 26 of 30 patients with cryptic leishmanial infection (16 asymptomatic, 4 with self-healing subclinical infection, and 10 posttreatment VL cases). Serum TNF alpha levels were also not elevated in 15 normal volunteers (11.3 +/- 15.6 pg/ml) and in 10 patients with tegumentary leishmaniasis (19.1 +/- 10.8 pg/ml). Leishmanial infection of human monocyte-derived macrophages enhanced the basal TNF alpha production by these cells, and this effect was further potentiated by treatment with recombinant interferon-gamma. After effective treatment of VL patients, serum TNF alpha levels dropped rapidly (129 +/- 112 vs. 9 +/- 13 pg/ml in 10 days), even before clinical parameters such as spleen size or parasitism, white blood cell count, or levels of hemoglobin returned to normal values. On the other hand, patients unresponsive to treatment remained with elevated levels (276 +/- 69 vs. 155 +/- 71 pg/ml in 10 days). Thus, serum TNF alpha levels in VL patients are a good parameter to monitor in determining host response to therapy.


Asunto(s)
Leishmaniasis Visceral/sangre , Factor de Necrosis Tumoral alfa/análisis , Enfermedad Aguda , Antimonio/uso terapéutico , Antiprotozoarios/uso terapéutico , Células Cultivadas , Terapia Combinada , Femenino , Humanos , Interferón gamma/farmacología , Interferón gamma/uso terapéutico , Leishmaniasis Visceral/diagnóstico , Leishmaniasis Visceral/terapia , Macrófagos/efectos de los fármacos , Macrófagos/parasitología , Masculino , Meglumina/uso terapéutico , Antimoniato de Meglumina , Compuestos Organometálicos/uso terapéutico , Proteínas Recombinantes
7.
Artículo en Inglés | MEDLINE | ID: mdl-1726921

RESUMEN

The activity of a platelet protein kinase that phosphorylates the alpha-chain of fibrinogen and the exogenous substrate histone was evaluated in 28 patients with Argentine hemorrhagic fever, grouped into: 13 mild, 6 moderate and 9 severe clinical forms. Blood samples were obtained before treatment with immune plasma, 4 days later and at recovery. Exogenous histone and fibrinogen phosphorylation were assayed with 25 Ci/mmol (gamma-32P)-ATP. Platelet counts and interferon (IFN) activity were performed simultaneously. Histone phosphorylation was found below normal in all patients during the acute phase of illness. This reduction was coincident with the lowest platelet count and the highest IFN titers. Fibrinogen phosphorylation was similarly reduced. Histone and fibrinogen phosphorylation were still low after 4 days of treatment, when IFN levels were almost undetectable. The low level of phosphorylation was not simply due to the reduced number of platelets and may be another evidence of a platelet abnormality in patients with Argentine hemorrhagic fever.


Asunto(s)
Plaquetas/enzimología , Fibrinógeno/metabolismo , Fiebre Hemorrágica Americana/sangre , Histonas/metabolismo , Proteínas Quinasas/sangre , Fiebre Hemorrágica Americana/terapia , Humanos , Inmunización Pasiva , Inmunoelectroforesis Bidimensional , Interferones/sangre , Fosforilación , Recuento de Plaquetas
8.
Artículo en Inglés | BINACIS | ID: bin-38128

RESUMEN

The activity of a platelet protein kinase that phosphorylates the alpha-chain of fibrinogen and the exogenous substrate histone was evaluated in 28 patients with Argentine hemorrhagic fever, grouped into: 13 mild, 6 moderate and 9 severe clinical forms. Blood samples were obtained before treatment with immune plasma, 4 days later and at recovery. Exogenous histone and fibrinogen phosphorylation were assayed with 25 Ci/mmol (gamma-32P)-ATP. Platelet counts and interferon (IFN) activity were performed simultaneously. Histone phosphorylation was found below normal in all patients during the acute phase of illness. This reduction was coincident with the lowest platelet count and the highest IFN titers. Fibrinogen phosphorylation was similarly reduced. Histone and fibrinogen phosphorylation were still low after 4 days of treatment, when IFN levels were almost undetectable. The low level of phosphorylation was not simply due to the reduced number of platelets and may be another evidence of a platelet abnormality in patients with Argentine hemorrhagic fever.

9.
Artículo en Inglés | BINACIS | ID: bin-51225

RESUMEN

The activity of a platelet protein kinase that phosphorylates the alpha-chain of fibrinogen and the exogenous substrate histone was evaluated in 28 patients with Argentine hemorrhagic fever, grouped into: 13 mild, 6 moderate and 9 severe clinical forms. Blood samples were obtained before treatment with immune plasma, 4 days later and at recovery. Exogenous histone and fibrinogen phosphorylation were assayed with 25 Ci/mmol (gamma-32P)-ATP. Platelet counts and interferon (IFN) activity were performed simultaneously. Histone phosphorylation was found below normal in all patients during the acute phase of illness. This reduction was coincident with the lowest platelet count and the highest IFN titers. Fibrinogen phosphorylation was similarly reduced. Histone and fibrinogen phosphorylation were still low after 4 days of treatment, when IFN levels were almost undetectable. The low level of phosphorylation was not simply due to the reduced number of platelets and may be another evidence of a platelet abnormality in patients with Argentine hemorrhagic fever.

10.
J Leukoc Biol ; 48(2): 149-55, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2164556

RESUMEN

TNF was not observed to have an antiviral effect on either HL60 or U937 cells. However, it did significantly enhance interferon (IFN)-gamma-mediated antiviral activity in U937 cells. Treatment of U937 cells with IFN-gamma enhanced (2'-5') oligo (A) synthetase activity (2.5-fold) but treatment with TNF did not. Combined treatment with TNF-alpha + IFN-gamma increased this activity dramatically (20-40-fold). This increase correlated with the very large increase in the (2'-5') oligo (A) synthetase mRNA level in U937 cells. No such effects were observed in HL60 cells. Furthermore, binding studies and cross-linking analysis showed that IFN-gamma modulated TNF-alpha receptors in U937 cells without altering their properties, but did not do so in HL60 cells.


Asunto(s)
2',5'-Oligoadenilato Sintetasa/biosíntesis , Antivirales/farmacología , Interferón gamma/farmacología , Leucemia Mielomonocítica Aguda/enzimología , Factor de Necrosis Tumoral alfa/farmacología , Sinergismo Farmacológico , Inducción Enzimática/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Humanos , Receptores de Superficie Celular/efectos de los fármacos , Receptores del Factor de Necrosis Tumoral , Proteínas Recombinantes/farmacología , Células Tumorales Cultivadas/efectos de los fármacos
11.
Immunology ; 69(1): 52-6, 1990 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1690177

RESUMEN

We studied IL-6 gene expression in human monocytes stimulated by muramyl dipeptide (MDP), a synthetic immunomodulator derived from mycobacterial cell walls. In control monocytes, two IL-6 transcripts of 3.4 kb and 1.6 kb were easily detected at 2.5 hr of culture and remained stable until 18 hr. In MDP-treated monocytes, three IL-6 RNA species displayed different kinetics of accumulation: a 3.4 kb RNA whose expression already reached its maximum after 2.5 hr exposure to MDP; a 1.6 kb RNA whose expression peaked at 5 hr; and a new RNA species of 1.4 kb which was transiently induced in early time of cell stimulation. TNF-alpha co-operated with MDP to increase IL-6 gene expression and secretion of biological active protein (measured by the hybridoma plasmacytoma growth factor assay). MDP exhibits a broad spectrum of immunomodulation properties such as adjuvant activity, enhancement of macrophage cytotoxicity against tumour and induction of non-specific resistance to intracellular agents. The results reported here suggest that these properties might be linked to the stimulation by MDP of genes coding for key cytokines such as IL-6, TNF and IL-1.


Asunto(s)
Acetilmuramil-Alanil-Isoglutamina/farmacología , Expresión Génica/inmunología , Interleucina-6/genética , Monocitos/inmunología , Factor de Necrosis Tumoral alfa/farmacología , Northern Blotting , Células Cultivadas , Sinergismo Farmacológico , Humanos , Interleucina-6/análisis , Monocitos/efectos de los fármacos , ARN/análisis
12.
Biochem Pharmacol ; 38(12): 1971-8, 1989 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-2500934

RESUMEN

We have previously shown that human interferon-gamma inhibited adenovirus multiplication in vitro in a dose-dependent fashion. This action was previous to capsid proteins synthesis and did not involve virus adsorption nor penetration. In this report we have analysed viral mRNA levels at early (7 hr post infection (p.i.)) or late (20 hr p.i.) times, as well as DNA replication in Wish cells pretreated with interferon-gamma and infected with adenovirus 5. Controls included untreated cells as well as cells treated with interferon-alpha, to which adenovirus are reported to be resistant. Transcription of adenovirus regions E1, E4, L1 and L2 has been analysed by Northern blot. Adenovirus DNA replication was determined by DNA-DNA hybridization with total adenovirus 2 DNA. We have also searched for adenovirus E1A proteins by immunoblot with a specific monoclonal antibody. Although pretreatment of cells with either interferon-alpha or interferon-gamma resulted in reduced amounts of E1 and E4 mRNA in the early phase of infection (7 hr p.i.), the near complete inhibition of viral DNA and late transcription was only achieved by interferon-gamma. Immunoblot has shown the absence of the 48-kD E1A protein in cells pretreated with interferon-gamma. The lack of this regulatory adenovirus protein may be involved in the inhibitory mechanism of interferon-gamma on adenovirus.


Asunto(s)
Adenovirus Humanos/fisiología , Interferón gamma/farmacología , Transcripción Genética/efectos de los fármacos , Replicación Viral/efectos de los fármacos , Actinas/metabolismo , Adenovirus Humanos/genética , Northern Blotting , Células Cultivadas , Replicación del ADN/efectos de los fármacos , ADN Viral/efectos de los fármacos , Regulación de la Expresión Génica , Humanos , Interferón Tipo I/farmacología , Hibridación de Ácido Nucleico , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , Proteínas Recombinantes
13.
Biochem Pharmacol ; 37(17): 3271-6, 1988 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-2969731

RESUMEN

We demonstrate the presence of high affinity receptors specific for interferon-gamma (IFN-gamma) in human lymphoblastoid Namalva cells. The presence of these receptors, whose binding affinity and cross-linking characteristics were not distinguishable from those of the corresponding receptors in sensitive cells, was not consistent with the lack of responsiveness of Namalva cells to IFN-gamma as regards growth inhibition, induction of 2'-5' oligoadenylate synthetase activity and inhibition of virus multiplication. Nevertheless, IFN-gamma enhanced the expression of two genes, HLA class II and c-myc. Although the mechanism of these IFN-gamma-mediated modifications is not understood, these results provide evidence that the IFN-gamma receptors present in Namalva cells are functional.


Asunto(s)
Interferón gamma/farmacología , Receptores Inmunológicos/fisiología , Interferencia Viral , 2',5'-Oligoadenilato Sintetasa/biosíntesis , División Celular/efectos de los fármacos , Reactivos de Enlaces Cruzados , Inducción Enzimática/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Antígenos HLA-D/genética , Humanos , Proteínas Proto-Oncogénicas/genética , ARN Mensajero/genética , Receptores de Interferón , Proteínas Recombinantes , Células Tumorales Cultivadas
14.
J Interferon Res ; 8(4): 473-81, 1988 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3171244

RESUMEN

We previously have reported the presence of interferon-beta 2 (IFN-beta 2) mRNA in PHA-stimulated human peripheral blood leukocytes (PBL), as well as in nonstimulated cells, although at a lower level. The IFN-beta 2 cloned from a leukocyte library appeared to be similar to that of the fibroblast IFN-beta 2 gene first described in fibroblasts. To assess the nature of the cell population in which the synthesis of IFN-beta 2 takes place, PBL were fractionated in adherent and nonadherent cells. The antiviral activity of the culture supernatants of adherent cells was characterized as the IFN-beta type by neutralization with polyclonal antibodies raised against purified fibroblast IFN-beta 2. IFN-beta 2 mRNA was observed in enriched monocyte populations and accumulated very rapidly, peaking at 2.5 h. RNA extracted from these cultures encoded in a reticulocyte lysate a protein immunoprecipitated by the anti-IFN-beta 2 antiserum. In addition, IFN-beta 2 secreted in monocyte supernatants also was immunoprecipitated by the specific antiserum and was able to compete with the fibroblast IFN-beta 2, suggesting a strong similarity between the fibroblast and monocyte proteins.


Asunto(s)
Regulación de la Expresión Génica , Interferón Tipo I/genética , Monocitos/análisis , ARN Mensajero/genética , Adhesión Celular , Humanos , Interferón Tipo I/análisis , Pruebas de Neutralización , Pruebas de Precipitina , Biosíntesis de Proteínas
16.
J Gen Virol ; 68 ( Pt 10): 2675-9, 1987 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3117971

RESUMEN

We have recently reported that adenovirus replication is inhibited by human recombinant interferon-gamma, but not by recombinant interferon-alpha, in a dose-dependent manner. The aim of this study was to determine whether the antiviral effect of recombinant interferon-gamma could be linked to interferon-induced alteration at the membrane level, inhibiting either adenovirus penetration of or release from WISH cells. Adsorption and penetration were investigated with an 125I-labelled adenovirus binding assay. To test defective virus release, the presence of newly synthesized virus proteins in the cytoplasmic and nuclear compartments was investigated. Binding studies showed that interferons-gamma and -alpha did not modify adenovirus attachment and penetration. Interferon-gamma but not interferon-alpha inhibited hexon protein synthesis in the cytosol as well as its accumulation in the nuclear compartment. The synthesis of polypeptides III, IV and VI was also inhibited. In cells infected before interferon-gamma treatment, its addition could be delayed up to 2 h after the infection to produce an inhibition of virus yield greater than 1 log10 unit (90% inhibition). We conclude that interferon-gamma acts on an intracellular step before or at adenovirus protein synthesis, probably through a mechanism not shared with interferon-alpha.


Asunto(s)
Adenovirus Humanos/crecimiento & desarrollo , Interferón gamma/farmacología , Replicación Viral/efectos de los fármacos , Línea Celular , Membrana Celular/fisiología , Endocitosis/efectos de los fármacos , Humanos , Receptores Virales/metabolismo , Proteínas Recombinantes , Interferencia Viral , Proteínas Virales/biosíntesis
17.
Proc Natl Acad Sci U S A ; 84(9): 2906-10, 1987 May.
Artículo en Inglés | MEDLINE | ID: mdl-3033669

RESUMEN

Interaction of human gamma-interferon (IFN-gamma) with a cell-surface receptor is known to be essential for the cell to become resistant to viral infection. Here we demonstrate that IFN-gamma, when present inside the cell, is also capable of inducing a permanent antiviral state. Mouse cells transformed with a truncated human cDNA encoding a mature IFN-gamma protein lacking the signal peptide accumulate high levels of intracellular human IFN-gamma. Not only do these cells acquire a permanent resistance to viral infection, they also exhibit all the biochemical characteristics normally observed after exposure to exogenous IFN. The observed loss of species specificity normally associated with IFN-gamma suggests that this restriction is strictly dependent on the interaction of the molecule with the cell-surface receptor.


Asunto(s)
Interferón gamma/inmunología , Receptores Virales/fisiología , 2',5'-Oligoadenilato Sintetasa/genética , Animales , Línea Celular , Enzimas de Restricción del ADN , Genes , Humanos , Interferón gamma/genética , Interferón gamma/farmacología , Células L/efectos de los fármacos , Células L/inmunología , Células L/microbiología , Ratones
18.
J Gen Virol ; 68 ( Pt 3): 941-4, 1987 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-3102686

RESUMEN

The susceptibility of adenovirus to the inhibitory effect of human interferons in vitro was investigated. We tested recombinant human interferons-alpha 2, -beta 1 and -gamma against adenovirus serotypes 1 and 5 (group C), 3 and 7a (group B), and a wild strain isolated from an acutely ill child who later died. Pretreatment of WISH cells with interferon-gamma for 24 h induced a dose-dependent inhibition of multiplication of all adenovirus strains tested, the TCID50 varying from 25 to 90 IU/ml. Human interferon-alpha 2 was unable to decrease adenovirus multiplication, while interferon-beta 1 at 2000 IU/ml slightly lowered the yield of adenovirus. Similar results were obtained in HEp-2 and FS-4 cells, while A-549 and peripheral blood mononuclear cells were insensitive to interferon-gamma. The difference between the effects of interferon-gamma and interferon-alpha and -beta on adenovirus multiplication in vitro suggests that its mechanism of antiviral action is different.


Asunto(s)
Adenovirus Humanos/genética , Interferón Tipo I/farmacología , Interferón gamma/farmacología , Proteínas Recombinantes/farmacología , Adenovirus Humanos/efectos de los fármacos , Adenovirus Humanos/crecimiento & desarrollo , Línea Celular , Niño , Replicación del ADN/efectos de los fármacos , Humanos , Especificidad de la Especie , Replicación Viral/efectos de los fármacos
19.
J Interferon Res ; 6(2): 161-70, 1986 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3088147

RESUMEN

Two interferon (IFN) messengers were synthesized in phytohemagglutinin (PHA)-activated lymphocytes: IFN-gamma mRNA and a messenger hybridizing with the IFN-beta 2 probe. They were induced rapidly and declined at a stage when overall RNA was still efficiently transcribed. The IFN-beta 2 mRNA (15S) present in the lymphocytes was slightly different from its fibroblastic counterpart (14S). The kinetics of the accumulation and decay of both lymphocyte IFN messengers differed when assessed by hybridization with the two IFN probes, IFN-gamma mRNA was not detected before mitogenic activation and accumulated for up to 15 h postactivation, while IFN-beta 2 mRNA accumulated even in the absence of PHA activation for up to 5 h, even though the activation raised the IFN-beta 2 mRNA level at 5 h. The disappearance of IFN messengers was prevented when cycloheximide was added 5 h after PHA activation, when the transcription of both messengers had already been turned on, suggesting the presence of the repressor mechanism proposed for IFN-beta 1 and IFN-beta 2 mRNAs in fibroblasts. In the absence of PHA activation, cycloheximide did not induce IFN-beta 2 mRNA transcription as it did in fibroblasts and moreover prevented the accumulation of the messenger observed in the control cells. In contrast to IFN-beta 2 mRNA, cycloheximide treatment of lymphocytes produced a slight accumulation of IFN-gamma mRNA. This accumulation was already detectable 6 h posttreatment and its level remained unchanged for up to 24 h. Addition of actinomycin D, 5 h after PHA activation, did not impair the shut off and accelerated the decay of IFN messengers.


Asunto(s)
Regulación de la Expresión Génica , Interferón Tipo I/genética , Interferón gamma/genética , Activación de Linfocitos , Linfocitos/metabolismo , Fitohemaglutininas/farmacología , Células Cultivadas , Ciclofosfamida/farmacología , Dactinomicina/farmacología , Humanos , ARN Mensajero/metabolismo
20.
Biochem Biophys Res Commun ; 135(3): 894-901, 1986 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-2421724

RESUMEN

Cotransformation with a plasmid containing a thymidine kinase gene (pTK2) and a plasmid encoding human IFN-gamma (pTG11) has been used to establish murine L cell lines expressing human IFN-gamma. The HuIFN-gamma gene was present in 30% of the tk+ cell lines and some of these secreted low levels of IFN into the culture medium. Two of the clones obtained after transformation were selected for detailed analysis. Clone 1-12 constitutively secreted very low levels of HuIFN-gamma in the culture medium. This antiviral activity was characterized by its species specificity and antigenicity as authentic human IFN-gamma In contrast, clone 3-47 produced a HuIFN-gamma activity which could only be detected intracellularly. This clone was resistant to infection both by Vesicular stomatitis (VSV) and Mengo viruses and contained increased levels of enzymes known to be induced by interferon. Our results suggest that clone 3-47 produces a non-secreted HuIFN-gamma like molecule which is able to trigger an antiviral state in the murine cell independent of the interaction with a specific IFN-gamma surface receptor.


Asunto(s)
Interferón gamma/genética , Proteínas Recombinantes/genética , 2',5'-Oligoadenilato Sintetasa/metabolismo , Animales , Compartimento Celular , Células Cultivadas , Citoplasma/metabolismo , Epítopos , Espacio Extracelular/metabolismo , Humanos , Interferón gamma/inmunología , Interferón gamma/metabolismo , Ratones , Proteínas Quinasas/metabolismo , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/metabolismo , Timidina Quinasa/genética , Transfección , Interferencia Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA